Steven Cohen’s Olema Pharmaceuticals OLMA Stock Holding History

Steven Cohen’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.4M	Buy	1,070,949 +999,842	+1,406%	+$13.4M	0.01%	1106
2026 Q1	$1.06M	Sell	71,107 -236,783	-77%	-$5.27M	﹤0.01%	2729
2025 Q4	$7.7M	Buy	307,890 +62,472	+25%	+$1.11M	0.01%	1518
2025 Q3	$2.4M	Buy	+245,418	New	+$1.47M	﹤0.01%	1356
2025 Q2	–	Sell	-1,441,690	Closed	-$5.42M	–	2484
2025 Q1	$5.42M	Sell	1,441,690 -2,229,136	-61%	-$11.2M	0.01%	897
2024 Q4	$21.4M	Sell	3,670,826 -16,548	-0.4%	-$165K	0.05%	425
2024 Q3	$44M	Buy	3,687,374 +475,447	+15%	+$6.08M	0.11%	212
2024 Q2	$34.8M	Buy	+3,211,927	New	+$34.8M	0.09%	288
2021 Q3	–	Sell	-80,000	Closed	-$2.24M	–	1185
2021 Q2	$2.24M	Sell	80,000 -13,900	-15%	-$396K	0.01%	717
2021 Q1	$3.12M	Buy	+93,900	New	+$4.02M	0.01%	664

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Steven Cohen's OLMA Position: Q2 2026 in Review

Steven Cohen increased its Olema Pharmaceuticals (OLMA) stake by 1,406% in Q2 2026, buying an estimated $13.4M and bringing the position to 1,070,949 shares worth $13.4M. The position accounts for 0.01% of the portfolio, ranked #1106.

Steven Cohen first reported a position in OLMA in Q1 2021 and has held it in 10 quarters since. The position peaked at $44M in Q3 2024. 182 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

Steven Cohen held 1,070,949 shares of Olema Pharmaceuticals worth $13.4M as of Q2 2026.
Steven Cohen bought 999,842 Olema Pharmaceuticals shares in Q2 2026, an estimated $13.4M.
Olema Pharmaceuticals made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1106 holding.
Steven Cohen first reported a position in Olema Pharmaceuticals in Q1 2021 and has held it in 10 quarters since.
Steven Cohen's Olema Pharmaceuticals position peaked at $44M in Q3 2024.
182 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.